With the pandemic ongoing, Goldman Sachs analysts are saying that the recovery in hospital procedure volumes and rebound in MedTech procedures could be delayed, a report says.
There could be at least one more COVID-19 wave following Omicron, the analysis says.
And despite the lack of any coherent timeline for “normalizing” things, analysts say there’s possibility that the disease will reach endemic status, which could give a boost to some commercial firms and those which work with hospitals and procedures.